These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

219 related items for PubMed ID: 26786399

  • 1. Pharmacokinetics and preliminary efficacy of two vaginal gel formulations of ultra-low-dose estriol in postmenopausal women.
    Delgado JL, Estevez J, Radicioni M, Loprete L, Moscoso Del Prado J, Nieto Magro C.
    Climacteric; 2016 Apr; 19(2):172-80. PubMed ID: 26786399
    [Abstract] [Full Text] [Related]

  • 2. The therapeutic effect of a new ultra low concentration estriol gel formulation (0.005% estriol vaginal gel) on symptoms and signs of postmenopausal vaginal atrophy: results from a pivotal phase III study.
    Cano A, Estévez J, Usandizaga R, Gallo JL, Guinot M, Delgado JL, Castellanos E, Moral E, Nieto C, del Prado JM, Ferrer J.
    Menopause; 2012 Oct; 19(10):1130-9. PubMed ID: 22914208
    [Abstract] [Full Text] [Related]

  • 3. Comparative uterine effects on ovariectomized rats after repeated treatment with different vaginal estrogen formulations.
    López-Belmonte J, Nieto C, Estevez J, Delgado JL, del Prado JM.
    Maturitas; 2012 Aug; 72(4):353-8. PubMed ID: 22683083
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Effects of ultralow topical estriol dose on vaginal health and quality of life in postmenopausal women who underwent surgical treatment for pelvic organ prolapse.
    Caruso S, Cianci S, Vitale SG, Matarazzo MG, Amore FF, Cianci A.
    Menopause; 2017 Aug; 24(8):900-907. PubMed ID: 28350758
    [Abstract] [Full Text] [Related]

  • 6. Local ultra-low-dose estriol gel treatment of vulvo-vaginal atrophy: efficacy and safety of long-term treatment.
    Villa P, Tagliaferri V, Amar ID, Cipolla C, Ingravalle F, Scambia G, Ricciardi W, Lanzone A.
    Gynecol Endocrinol; 2020 Jun; 36(6):535-539. PubMed ID: 31847628
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Low-dose, vaginally administered estrogens may enhance local benefits of systemic therapy in the treatment of urogenital atrophy in postmenopausal women on hormone therapy.
    Palacios S, Castelo-Branco C, Cancelo MJ, Vázquez F.
    Maturitas; 2005 Feb 14; 50(2):98-104. PubMed ID: 15653006
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Evaluation of the efficacy and safety of hyaluronic acid vaginal gel to ease vaginal dryness: a multicenter, randomized, controlled, open-label, parallel-group, clinical trial.
    Chen J, Geng L, Song X, Li H, Giordan N, Liao Q.
    J Sex Med; 2013 Jun 14; 10(6):1575-84. PubMed ID: 23574713
    [Abstract] [Full Text] [Related]

  • 12. Ultra-low-dose estriol and Lactobacillus acidophilus vaginal tablets (Gynoflor(®)) for vaginal atrophy in postmenopausal breast cancer patients on aromatase inhibitors: pharmacokinetic, safety, and efficacy phase I clinical study.
    Donders G, Neven P, Moegele M, Lintermans A, Bellen G, Prasauskas V, Grob P, Ortmann O, Buchholz S.
    Breast Cancer Res Treat; 2014 Jun 14; 145(2):371-9. PubMed ID: 24718774
    [Abstract] [Full Text] [Related]

  • 13. Effect of ultra-low-dose estriol and lactobacilli vaginal tablets (Gynoflor®) on inflammatory and infectious markers of the vaginal ecosystem in postmenopausal women with breast cancer on aromatase inhibitors.
    Donders G, Bellen G, Neven P, Grob P, Prasauskas V, Buchholz S, Ortmann O.
    Eur J Clin Microbiol Infect Dis; 2015 Oct 14; 34(10):2023-8. PubMed ID: 26223323
    [Abstract] [Full Text] [Related]

  • 14. Continuous low dose estradiol released from a vaginal ring versus estriol vaginal cream for urogenital atrophy.
    Barentsen R, van de Weijer PH, Schram JH.
    Eur J Obstet Gynecol Reprod Biol; 1997 Jan 14; 71(1):73-80. PubMed ID: 9031963
    [Abstract] [Full Text] [Related]

  • 15. Systemic bioavailability of estriol following single and repeated vaginal administration of 0.03 mg estriol containing pessaries.
    Buhling KJ, Eydeler U, Borregaard S, Schlegelmilch R, Suesskind M.
    Arzneimittelforschung; 2012 Aug 14; 62(8):378-83. PubMed ID: 22692777
    [Abstract] [Full Text] [Related]

  • 16. Monurelle Biogel® vaginal gel in the treatment of vaginal dryness in postmenopausal women.
    Nappi RE, Cagnacci A, Becorpi AM, Nappi C, Paoletti AM, Busacca M, Martella S, Bellafronte M, Tredici Z, Di Carlo C, Corda V, Vignali M, Bagolan M, Sardina M.
    Climacteric; 2017 Oct 14; 20(5):467-475. PubMed ID: 28657769
    [Abstract] [Full Text] [Related]

  • 17. Randomized, double-blind, placebo-controlled clinical trial for evaluating the efficacy of fractional CO2 laser compared with topical estriol in the treatment of vaginal atrophy in postmenopausal women.
    Cruz VL, Steiner ML, Pompei LM, Strufaldi R, Fonseca FLA, Santiago LHS, Wajsfeld T, Fernandes CE.
    Menopause; 2018 Jan 14; 25(1):21-28. PubMed ID: 28763401
    [Abstract] [Full Text] [Related]

  • 18. Low-dose vaginal estrogens or vaginal moisturizer in breast cancer survivors with urogenital atrophy: a preliminary study.
    Biglia N, Peano E, Sgandurra P, Moggio G, Panuccio E, Migliardi M, Ravarino N, Ponzone R, Sismondi P.
    Gynecol Endocrinol; 2010 Jun 14; 26(6):404-12. PubMed ID: 20196634
    [Abstract] [Full Text] [Related]

  • 19. Low dose estriol pessaries for the treatment of vaginal atrophy: a double-blind placebo-controlled trial investigating the efficacy of pessaries containing 0.2mg and 0.03mg estriol.
    Griesser H, Skonietzki S, Fischer T, Fielder K, Suesskind M.
    Maturitas; 2012 Apr 14; 71(4):360-8. PubMed ID: 22285095
    [Abstract] [Full Text] [Related]

  • 20. Ultralow 0.03 mg vaginal estriol in postmenopausal women who underwent surgical treatment for stress urinary incontinence: effects on quality of life and sexual function.
    Caruso S, Cianci A, Sarpietro G, Matarazzo MG, Panella M, Cianci S.
    Menopause; 2020 Feb 14; 27(2):162-169. PubMed ID: 31834156
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.